Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UGT1A1 genotype-guided CPT-11 + platinum regimens observational study
jRCT1080220914
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of irinotecan in small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), Cervical Cancer (CC) and 2 more, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
irinotecan
03
Conditions
small cell lung cancer (SCLC)non-small cell lung cancer (NSCLC)Cervical Cancer (CC)ovarian cancergastric cancer (GC)
Beyond the preview
Go deeper on jRCT1080220914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220914.